Vanda Ruling Offers New Guide To Generic Labeling Disputes
By Shashank Upadhye · September 11, 2026, 5:42 PM EDT
The U.S. Court of Appeals for the District of Columbia Circuit's Aug. 18 decision in Vanda Pharmaceuticals v. U.S. Food and Drug Administration presents an unusual Hatch-Waxman Act result: Vanda won...
To view the full article, register now.